Frankfurt - Delayed Quote EUR
Terns Pharmaceuticals Inc (430.F)
As of 8:05 AM GMT+2. Market Open.
Growth Estimates
CURRENCY IN USD | 430.F | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | -- |
Next Qtr. | -- | -- | -- | -- |
Current Year | -- | -- | -- | -- |
Next Year | -- | -- | -- | -- |
Next 5 Years (per annum) | -- | -- | -- | -- |
Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
Reiterates | BMO Capital: Outperform to Outperform | 9/16/2024 |
Maintains | JMP Securities: Market Outperform to Market Outperform | 9/10/2024 |
Reiterates | JMP Securities: Market Outperform to Market Outperform | 9/3/2024 |
Reiterates | BMO Capital: Outperform to Outperform | 8/6/2024 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 5/14/2024 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 4/30/2024 |
Related Tickers
J7Z.F Jazz Pharmaceuticals plc
103.50
-0.72%
0RK.F Exscientia plc
4.6000
-2.08%
20D0.F Cidara Therapeutics, Inc.
10.20
0.00%
38I.F Intellia Therapeutics, Inc.
18.80
-2.67%
J90.F NurExone Biologic Inc.
0.3500
-7.41%
VX1.F Vertex Pharmaceuticals Incorporated
440.55
-0.44%
1VT.F Viking Therapeutics, Inc.
59.10
-0.17%
NRX.V NurExone Biologic Inc.
0.5400
0.00%
XBIO Xenetic Biosciences, Inc.
3.7650
+1.76%
CDTX Cidara Therapeutics, Inc.
11.22
-0.36%